Pharmatech Announces New Controller

April 23, 2014 - PRLog -- Pharmatech recently announced that it has hired Pat Mancini as its new controller.

Mancini previously held the position of Director of Finance, North America, for TFS, a global CRO.  Over his career at Beardsworth Consulting Group, Inc., he was constantly promoted and held positions of increasing responsibility. From his initial promotion from Operations Analyst, to Finance Manager, he continued his upward climb to Controller, Business Solutions Manager and finally Chief Financial Officer. With his vast knowledge of finance in a clinical research setting, Mancini’s team-focused approach and track record of success is a great asset to Pharmatech, as well as their clients and sites.

Rob Bohacs, CEO, stated: “As Pharmatech continues to improve its executive leaders, Pat Mancini stands out as a rare and welcome addition to our team. Our continuous effort to employ only the highest caliber candidates is what has lead to Pharmatech’s success and Pat’s appointment is no exception.”

Pharmatech, headquartered in Denver, Colorado, is a Site Management Organization (SMO) and Contract Research Organization (CRO) with a focus on oncology clinical research. Through an organized network of cancer clinics, the company focuses on advancing the development of products for a broad range of pharmaceutical and biotechnology companies, and promoting the inclusion of clinical trials in the spectrum of patient treatment options.